New Safety Concerns: More For Medical Entities To Oversee, Manage

By Daniels Porco & Lusardi, LLP | Published March 23, 2017 | Posted in Health Care Law | Tagged Tags: Health Care Law | Comments Off on New Safety Concerns: More For Medical Entities To Oversee, Manage

Opportunities, yes. And challenges across all dimensions, too, with related management and liability concerns — a reality that is simply a commonplace for American medical actors across all spheres. Any individual in New York or elsewhere who is even remotely connected with the medical industry in any capacity flatly knows the unrelenting bureaucratic and regulatory Read More

FDA Drug Approval: Too Fast, Too Slow Or Just About Right?

By Daniels Porco & Lusardi, LLP | Published March 8, 2017 | Posted in Health Law | Tagged Tags: Health Law | Comments Off on FDA Drug Approval: Too Fast, Too Slow Or Just About Right?

In the realm of federal oversight over marketplace drug approval, do officials from the U.S. Food and Drug Administration act so cautiously that they dangerously slow up the process and materially delay the marketplace entrance of new drugs and medications that many consumers badly need? Or, conversely, do they signal approval in precipitous fashion, so Read More

New Safety Concerns: More For Medical Entities To Oversee, Manage

FDA Drug Approval: Too Fast, Too Slow Or Just About Right?

PAWLING OFFICE

CARMEL OFFICE

Washington, D.C. Office

Contact Form